Skip to main content
Log in

Use of administrative hospital database to identify adverse drug reactions in a Pediatric University Hospital

  • Pharmacoepidemiology and Prescription
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Purpose

The aim of the study was to detect adverse drug reactions (ADRs) in pediatric inpatients using the medical administrative database “Programme de Médicalisation des Systèmes d′Information” (PMSI) and to compare these cases ADRs with those spontaneously reported to a regional PharmacoVigilance (PV) Centre.

Methods

The study was conducted from January 2008 to December 2011 in the Children University Hospital of Toulouse (Midi-Pyrénées, South-west France). From PMSI database, all discharge summaries including selected ICD-10 codes (10th International Classification of Diseases) were analyzed. All ADRs spontaneously reported by the Children Hospital of Toulouse and registered in the French PV Database (FPVDB) were included. The capture–recapture method was applied to estimate the incidence of ADRs.

Results

During the study period, we identified 60 reports from the PMSI database and 200 from the FPVDB. The rate of “serious” ADRs was higher in PMSI reports (74.6 % vs 38.9 %, p < 0.0001). The most frequent ADRs reported were musculoskeletal (12.4 %) and central (11.3 %) ADRs in PMSI database versus cutaneous (22.4 %) and general (17.5 %) ADRs in FPVDB. The most frequently suspected drugs were antineoplastic drugs (31.1 %) in PMSI database versus anti-infectives (38.2 %) in FPVDB. The estimated number of ADRs was 717 [95 % confidence interval (CI) 513, 921], and the incidence of ADRs among admissions was 0.6 % (95 % CI 0.4, 0.8).

Conclusions

Use of PMSI database improves from around 30 % detection of ADRs in children. In comparison with classical pharmacovigilance database, it also allows to detect different ADRs and drugs, thus enhancing safe medicine use for pediatric patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Aagaard L, Christensen A, Hansen EH (2010) Information about adverse drug reactions reported in children: a qualitative review of empirical studies. Br J Clin Pharmacol 70:481–491

    Article  PubMed Central  PubMed  Google Scholar 

  2. Choonara I (2013) Educational paper: aspects of clinical pharmacology in children (2013) pharmacovigilance and safety. Eur J Pediatr 172:577–580

    Article  CAS  PubMed  Google Scholar 

  3. Gallagher R, Mason J, Bird K, Kirkham J, Peak M, Williamsom P, Nunn A, Turner M, Pirmohamed M, Smyth R (2012) Adverse drug reactions causing admission to a paediatric hospital. PloS One 7:e50127

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Impicciatore P, Choonara I, Clarkson A, Provasi D, Pandolfini C, Bonati M (2001) Incidence of adverse drug reactions in paediatric in/out patients: a systematic review and meta-analysis of prospective studies. Br J Clin Pharmacol 52:77–83

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Smyth RMD, Gargon E, Kirkham J, Cresswell L, Golder S, Smyth R, Williamson P (2012) Adverse drug reactions in children—a systematic review. PloS One 7:1–24

    Google Scholar 

  6. Johann-Liang R, Wyeth J, Chen M, Cope J (2009) Pediatric drug surveillance and the food and drug administration’s adverse event reporting system: an overview of reports, 2003–2007. Pharmacoepidemiol Drug Saf 18:24–27

    Article  PubMed  Google Scholar 

  7. Autret-Leca E, Marchand MS, Cissokoa H, Beau-Salinas F, Jonville-Bera AP (2012) Pharmacovigilance in children. Arch Pediatr 19:848–855

    Article  CAS  PubMed  Google Scholar 

  8. Horen B, Montastruc JL, Lapeyre-Mestre M (2002) Adverse drug reactions and off-label drug use in paediatric outpatients. Br J Clin Pharmacol 54(6):665–670

    Article  PubMed Central  PubMed  Google Scholar 

  9. Milne CP, Davis J (2014) The pediatric studies initiative: after 15 years have we reached the limits of the law? Clin Ther 95(1):98–109

    Article  Google Scholar 

  10. Haslund-Krog S, Mathiasen R, Christensen HR, Holst H (2014) The impact of legislation on drug substances used off-label in paediatric wards—a nationwide study. Eur J Clin Pharmacol 70(4):448–452

    Article  Google Scholar 

  11. Aagaard L, Weber CB, Hansen EH (2010) Adverse drug reactions in the paediatric population in Denmark: a retrospective analysis of reports made to the Danish Medicines Agency from 1998 to 2007. Drug Saf 33:327–339

    Article  PubMed  Google Scholar 

  12. Miguel A, Azevedo LF, Lopes F, Freitas A et al (2013) Methodologies for the detection of adverse drug reactions: comparison of hospital databases, charts review and spontaneous reporting. Pharmacoepidemiol Drug Saf 22:98–102

    Article  PubMed  Google Scholar 

  13. Martin-Latry K, Bégaud B (2010) Pharmacoepidemiological research using French reimbursement databases: yes we can! Pharmacoepidemiol Drug Saf 19:256–265

    Article  PubMed  Google Scholar 

  14. Neubert A, Doormann H, Weiss J, Criegge-Rieck M, Ackermann A, Levy M, Brune K, Rasher W (2006) Are computerised monitoring systems of value to improve pharmacovigilance in paediatric patients? Eur J Clin Pharmacol 62:959–965

    Article  PubMed  Google Scholar 

  15. Neubert A, Sturkenboom MC, Murray ML, Verhamme KM, Nicolosi A, Giaquinto C, Ceci A, Wong IC, TEDDY Network of Excellence (2008) Databases for pediatric medicine research in Europe—assessment and critical appraisal. Pharmacoepidemiol Drug Saf 17:1155–1167

    Article  PubMed  Google Scholar 

  16. Bates DW, Evans RS, Murff H, Stetson PD, Pizziferri L, Hripcsak G (2003) Detecting adverse events using information technology. J Am Med Inform Assoc 10:115–128

    Article  PubMed Central  PubMed  Google Scholar 

  17. Tavassoli N, Duchayne E, Sadaba B, Desboeuf K, Sommet A, Lapeyre-Mestre M, Muoz MJ, Sie P, Honorato J, Montastruc JL, Bagheri H (2007) Detection and incidence of drug-induced agranulocytosis in hospital: a prospective analysis from laboratory signals. Eur J Clin Pharmacol 63:221–228

    Article  CAS  PubMed  Google Scholar 

  18. Lugardon S, Desboeuf K, Fernet P, Montastruc JL, Lapeyre-Mestre M (2006) Using a capture-recapture method to assess the frequency of adverse drug reactions in a French university hospital. Br J Clin Pharmacol 62:225–231

    Article  PubMed Central  PubMed  Google Scholar 

  19. Begaud B, Evreux JC, Jouglard J, Lagier G (1985) Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France. Therapie 40:111–118

    CAS  PubMed  Google Scholar 

  20. Edwards IR, Aronson JK (2000) Adverse drug reactions: definitions, diagnosis, and management. Lancet 356:1255–1259

    Article  CAS  PubMed  Google Scholar 

  21. Gallay A, Nardonnel A, Vaillant V, Desenclos JC (2002) The capture-recapture applied to epidemiology: principles, limits and application. Rev Epidemiol Sante Publique 50:219–232

    CAS  PubMed  Google Scholar 

  22. Weill A, Païta M, Tuppin P, Fagot JP, Neumann A, Simon D, Ricordeau P, Montastruc JL, Allemand H (2010) Benfluorex and valvular heart disease: a cohort study of a million people with diabetes mellitus. Pharmacoepidemiol Drug Saf 19:1256–1262

    Article  CAS  PubMed  Google Scholar 

  23. Couffignal AL, Lapeyre-Mestre M, Bonhomme C, Bugat R, Montastruc JL (2000) Adverse effects of anticancer drugs: a propos of a pharmacovigilance study at a specialized oncology institution. Therapie 55:635–641

    CAS  PubMed  Google Scholar 

  24. Jouanjus E, Leymarie F, Tubery M, Lapeyre-Mestre M (2011) Cannabis-related hospitalizations: unexpected serious events identified through hospital databases. Br J Clin Pharmacol 71:758–765

    Article  PubMed Central  PubMed  Google Scholar 

  25. Jouanjus E, Pourcel L, Saivin S, Molinier L, Lapeyre-Mestre M (2012) Use of multiple sources and capture-recapture method to estimate the frequency of hospitalizations related to drug abuse. Pharmacoepidemiol Drug Saf 21:733–741

    Article  PubMed  Google Scholar 

  26. Daveluy A, Miremont-Salamé G, Kostrzewa A, Couret A, Lacoin L, Lecomte C, Moore N, Gilleron V, Haramburu F (2012) Identification of abuse and dependence cases through a hospital database. Pharmacoepidemiol Drug Saf 21:1344–1349

    Article  CAS  PubMed  Google Scholar 

  27. Seiber EE (2007) Physician code creep: evidence in Medicaid and State Employee Health Insurance billing. Health Care Financ Rev 28:83–93

    PubMed  Google Scholar 

  28. Cox AR, Anton C, Goh CHF, Easter M, Langford NJ, Ferner RE (2001) Adverse drug reactions in patients admitted to hospital identified by discharge ICD-10 codes and by spontaneous reports. Br J Clin Pharmacol 52:337–339

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  29. Lapeyre-Mestre M, Gary J, Machelard-Roumagnac M, Bonhomme C, Bugat R, Montastruc JL (1997) Incidence and cost of adverse drug reactions in a French cancer institute. Eur J Clin Pharmacol 53:19–22

    Article  CAS  PubMed  Google Scholar 

  30. Salmeron-Garcia A, Cabeza Barrera J, Vergara Pavon MJ et al (2012) Detection of adverse drug reactions through the minimum basic data set. Pharm World Sci 32:322–328

    Article  Google Scholar 

Download references

Acknowledgments

We would like to thank Charlotte Benzina, Lucie Cantaloube, and Caroline Rossard for data collection.

Conflict of interest

The authors declare that they have no conflict of interest

Author contributions

Dr Durrieu conceptualized and supervised the study, drafted the initial manuscript, and reviewed and revised the manuscript. Dr Batz designed the study and carried out the initial data analysis. Dr Rousseau carried out the final analysis and reviewed the manuscript. Dr Bondon-Guitton contributed to the concept and the design of the study and reviewed the manuscript. Dr Petiot contributed to the concept of the study, extracted data from the administrative hospital database, and reviewed the manuscript. Pr Montastruc reviewed and revised the manuscript. All authors approved the final manuscript as submitted.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G. Durrieu.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Durrieu, G., Batz, A., Rousseau, V. et al. Use of administrative hospital database to identify adverse drug reactions in a Pediatric University Hospital. Eur J Clin Pharmacol 70, 1519–1526 (2014). https://doi.org/10.1007/s00228-014-1763-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-014-1763-1

Keywords

Navigation